Skip to Content

EOS imaging Appoints Pierre Schwich as Chief Financial Officer

by July 17, 2017 General

EOS imaging (Paris:EOSI) (Euronext, FR0011191766 – EOSI), the
pioneer in 2D/3D orthopaedic medical imaging, today announced the
appointment of Pierre Schwich as Chief Financial Officer (CFO),
effective immediately.

Marie Meynadier, CEO of EOS imaging, says: “We are pleased to welcome
Pierre to our team. His extensive experience with healthcare and
technology growth companies, listed in France and in the U.S., will
contribute to the ongoing expansion of our business. He joins us at a
key stage of our development and his skills will be extremely valuable
as we execute on our growth strategy.”

Pierre Schwich brings over 20 years of experience in Financial
Management at high growth, public and private companies in the
healthcare and technology sectors. Before joining EOS imaging, he was
CFO of Pharnext, where he successfully led the company’s initial public
offering. He was previously Financial and Legal Director of Oceasoft, a
company specialized in connected sensors, and CFO of Cellectis where he
contributed to a private placement with U.S. investors. Pierre was also
Deputy CEO, in charge of finances, of Genesys Conferencing, a public
company listed in Paris and on the NASDAQ, with a strong activity in the

After graduating from the MinesParisTech Engineering School, Pierre
began his career in the industrial sector (Corning, Danone,
Hewlett-Packard) before turning to Private Equity, as Investment
Director at 3i, then General Secretary of Siparex. He has developed an
extensive experience in mergers and acquisitions, fund raising, LBO and
business transfer operations, along with financial and administrative
team management.

For more information, please visit

EOS imaging has been chosen to be included in the new EnterNext©
PEA-PME 150 index, composed of 150 French companies and listed on
Euronext and Euronext GROWTH markets in Paris.

EOS Imaging is listed on Compartment C of Euronext Paris

ISIN: FR0011191766 – Ticker: EOSI

About EOS imaging

EOS imaging designs, develops, and markets EOS®, an
innovative medical imaging system dedicated to osteo-articular
pathologies and orthopaedics, as well as associated solutions. The
Company is authorized to market in 51 countries, including the United
States (FDA), Japan and the European Union (EC). The Group posted 2016
revenues of €30.8 million and employs 132 people at December 2016,
including an R&D team of 43 engineers. The Group is based in Paris and
has five subsidiaries in Besançon (France), Cambridge (Massachusetts),
Montreal (Canada), Frankfurt (Germany) and Singapore.